Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.India-based Panacea Biotec has partnered with Refana USA for the development, manufacturing and distribution of a Covid-19 vaccine candidate worldwide.
The partners intend to form a joint venture company to enable equitable global access to the vaccine. The joint venture will be based in Ireland.
Panacea Biotec and Refana will work on a whole inactivated virus-based vaccine against Covid-19. As part of the deal, Panacea Biotec will carry out product development and commercial manufacturing, while the joint venture will be responsible for clinical development and regulatory submissions globally.
Read more on pharmaceutical-technology.com